Living with Congenital dyserythropoietic anemia type 4
A newly described inherited blood condition with severe anemia from birth because red blood cells form poorly and break down early.
Understanding Congenital dyserythropoietic anemia type 4
Red blood cell production is not effective, and cells break down early (hemolysis). Features include an enlarged liver and spleen, immature red blood cells in the blood, and in some cases thickened heart muscle, a prominent forehead or genital differences. It starts in newborns and infants.
Signs & symptoms
Symptoms vary from person to person. GARD lists these among the most common:
- Severe anemia from birth
- Early breakdown of red blood cells (hemolytic anemia)
- Enlarged liver and spleen
- Immature red blood cells in the blood
- Thickened heart muscle in some
- Prominent forehead
Not everyone has every symptom. GARD's list comes from the Human Phenotype Ontology.
Diagnosis
- 1Talk with your doctor
Share the symptoms you've noticed, when they started and your family health history. Notes and photos can help.
- 2See a specialist
Specialists who may be involved include blood and bone marrow specialists and genetic specialists.
- 3Consider genetic testing
Changes in KLF1 are linked to this condition. Genetic testing and counseling can help confirm a diagnosis and explain what it means for your family.
Care & treatment
- Care team
- Blood and bone marrow specialists (hematologists); Genetic specialists (geneticists)
- Expert care
- Ask about multidisciplinary care centers for rare conditions
- Treatment
- GARD doesn't list specific treatments for this condition. Your care team will tailor care to your symptoms.
- Research
- Clinical trials and observational studies may be options. See the research section below.
General information, not medical advice. Your care team makes the decisions.
Everyday life
Living with a rare condition is easier with support.
- Connect with rare disease patient organizations for support
- Keep notes on symptoms, changes and questions for appointments
- Ask about patient registries that help research
- Look into financial aid and travel resources for care visits
Quick facts
Changes in the KLF1 gene are listed. It is autosomal dominant, so one changed copy of the gene is enough to cause it.
Also known as: anemia, congenital dyserythropoietic, type iva; cda due to klf1 mutation; cda iv; cda type 4; cda type iv; cda, type iva
Patient organizations
Rare-disease groups that can help
- Global GenesRare Diseases · United States
- National Organization for Rare DisordersRare Diseases · United States
- Genetic AllianceRare Diseases · United States
- RARE FoundationRare Diseases · United States
You are more than your diagnosis
Perspectives from people navigating life with Congenital dyserythropoietic anemia type 4.
Explore research for Congenital dyserythropoietic anemia type 4
Explore actively recruiting Congenital dyserythropoietic anemia type 4 studies with HealthSpark.
Find actively recruiting studies for Congenital dyserythropoietic anemia type 4 with HealthSpark. Share your city to explore research near you.
- Recruiting studies from ClinicalTrials.gov
- Share your city to look for research near you
- Eligibility is confirmed by the study team
Powered by HealthSpark, our AI chat helper
I can help you find recruiting Congenital dyserythropoietic anemia type 4 studies. Enter a ZIP code, address or city below and I'll look within 50 miles.
Powered by HealthSpark, our AI chat helper · Study information from ClinicalTrials.gov · Eligibility is confirmed by the study team.
Get Signals for Congenital dyserythropoietic anemia type 4
Stay in the loop with community stories and updates from medical researchers.
Create a living journal that talks back
HealthStory evolves private journaling with a living AI journal that talks back and asks thoughtful questions, helping you capture your Congenital dyserythropoietic anemia type 4 experiences more deeply and prepare for better conversations with your doctors and care team.
Your journal is private. Sharing your story publicly is a separate choice, made with Share your story above.